AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUL 25 - (NewsRx.com & NewsRx.net) --
Researchers testing an experimental HIV vaccine have injected the first of 40 volunteers in Trinidad for a study sponsored by a U.S. health agency and the French and U.S. manufacturers.
"The inspiration to join the program came from knowing people who had been infected that motivated me to help somehow," the 28-year-old male volunteer said.
He was injected June 20, 2001, with the first shot of the combination vaccine: ALVAC manufactured by Aventis Pasteur of Lyon, France, and rg120 MN made by VaxGen of San Francisco, California. Both are synthetic vaccines that cannot give a person HIV, according to the U.S. National Institute of Allergy and Infectious Diseases, which is sponsoring the trials.
A Trinidadian government ethics committee gave its approval in November 2000, and "our Medical Ethics Committee has ensured that the researchers will give the volunteer the best medical treatment that is available worldwide," said health minister Hamza Rafeeq.
The Caribbean, with 2% HIV infection rate, has the highest incidence of AIDS after Africa. Officials estimate at least 17,000 are infected with HIV in Trinidad and Tobago, a two-island Caribbean nation of 1.3 million people.
"With over 80% of the cases of HIV and AIDS in the developing world, we have a responsibility to be part of the exercise to find a vaccine," said Courtney Bartholomew, director of the Medical Research Foundation of Trinidad and Tobago, which is conducting the trial.
Source: HighBeam Research, First Trinidadian Volunteer Injected With Experimental...